Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Linlin Wang & Zanling Zhang. (2022) Comment about the safety of intravenous voriconazole formulated with sulfobutylether beta-cyclodextrin. Expert Opinion on Drug Safety 21:1, pages 133-134.
Read now
Read now
Sara Blanco-Dorado, Cristina Cea-Arestin, Alba González Carballo, Ana Latorre-Pellicer, Olalla Maroñas Amigo, Gema Barbeito Castiñeiras, María Luisa Pérez del Molino Bernal, Manuel Campos-Toimil, Anxo Fernández-Ferreiro & María J. Lamas. (2019) An Observational Study of the Efficacy and Safety of Voriconazole in a Real-Life Clinical Setting. Journal of Chemotherapy 31:1, pages 49-57.
Read now
Read now
Werner J. Heinz, Gerda Silling & Angelika Böhme. (2011) Utilisation, efficacy and safety of voriconazole: prospective, non-interventional study on treatment of IFIs in clinical practice. Current Medical Research and Opinion 27:2, pages 335-342.
Read now
Read now
F. Álvarez-Lerma, F. Mariscal, E. Quin-Tana, G. Rialp, J. Díaz-Regañón, M.J. Pérez San José & B. Álvarez-Sánchez. (2010) Impact of the Administration of Liposomal Amphotericin B in Patients with Renal Function Impairment at Initiation of Treatment. Journal of Chemotherapy 22:4, pages 285-287.
Read now
Read now
F. Álvarez-Lerma, F. Mariscal, E. Quintana, G. Rialp, J. Díaz-Regañón, M.J. Pérez, B. Álvarez-Sánchez & I. Ausín Aoiz. (2009) Use of Liposomal Amphotericin B in Critically III Patients: A Retrospective, Multicenter, Clinical Study. Journal of Chemotherapy 21:3, pages 330-337.
Read now
Read now
F. Álvarez-Lerma, A. Allepuz-Palau, M.P. Gracia, M. Ágeles León, A. Navarro, H. Sáchez-Ruí, J. R. Iruretagoyena & P. Luque-Góez. (2008) Impact of Intravenous Administration of Voriconazole in Critically Ill Patients with Impaired Renal Function. Journal of Chemotherapy 20:1, pages 93-100.
Read now
Read now
Marta Stanzani, Fabio Tumietto, Nicola Vianelli & Michele Baccarani. (2007) Update on the treatment of disseminated fusariosis: Focus on voriconazole. Therapeutics and Clinical Risk Management 3:6, pages 1165-1173.
Read now
Read now
Javier Pemán, Miguel Salavert, Emilia Cantón, Isidro Jarque, Eva Romá, Rafael Zaragoza, Ángel Viudes & Miguel Gobernado. (2006) Voriconazole in the management of nosocomial invasive fungal infections. Therapeutics and Clinical Risk Management 2:2, pages 129-158.
Read now
Read now
Articles from other publishers (11)
Elisabeth Paramythiotou, Frantzeska Frantzeskaki, Aikaterini Flevari, Apostolos Armaganidis & George Dimopoulos. (2014) Invasive Fungal Infections in the ICU: How to Approach, How to Treat. Molecules 19:1, pages 1085-1119.
Crossref
Crossref
Santiago Grau, Rafael de la Cámara, Francisco J Sabater, Isidro Jarque, Enric Carreras, Miguel A Casado & Miguel A Sanz. (2012) Cost-effectiveness of posaconazole versusfluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain. BMC Infectious Diseases 12:1.
Crossref
Crossref
David M. Cross, Gary Chmielewski, Elise M. Lewis, Lei Liu, Michael S. Modesitt, Sharon L. Ripp, Christopher M. Sawaryn & Christopher J. Bowman. (2012) Non-clinical safety assessment and toxicokinetics of voriconazole and anidulafungin in the juvenile rat: A combination study design in support of a Paediatric Investigation Plan. Regulatory Toxicology and Pharmacology 63:1, pages 29-39.
Crossref
Crossref
F. Jacobs, D. Selleslag, M. Aoun, A. Sonet & A. Gadisseur. (2011) An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole. European Journal of Clinical Microbiology & Infectious Diseases 31:6, pages 1173-1179.
Crossref
Crossref
Rafael Zaragoza & Javier Pemán. (2012) Opciones terapéuticas para el tratamiento antifúngico en el paciente crítico. Revista Iberoamericana de Micología 29:2, pages 108-113.
Crossref
Crossref
Márcio Borges Sá & José Garnacho Montero. (2008) Papel de anidulafungina en el paciente crítico. Enfermedades Infecciosas y Microbiología Clínica 26, pages 35-43.
Crossref
Crossref
M?rcio Borges S?Rafael Zaragoza. (2008) Critical overview of clinical guidelines relating to invasive fungal infections. International Journal of Antimicrobial Agents 32, pages S155-S159.
Crossref
Crossref
Francisco Álvarez Lerma. (2007) El papel de voriconazol en pacientes críticos con micosis invasoras. Revista Iberoamericana de Micología 24:3, pages 209-212.
Crossref
Crossref
Georg MaschmeyerAntje Haas. (2006) Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections. Future Microbiology 1:4, pages 365-385.
Crossref
Crossref
Rafael Zaragoza & Javier Pemán. (2006) Infección fúngica invasora en el paciente crítico: diferentes opciones terapéuticas y una misma estrategia. Revista Iberoamericana de Micología 23:2, pages 59-63.
Crossref
Crossref
Yoshihisa Tateishi, Hiroyuki Hirasawa, Shigeto Oda, Kazuya Nakanishi, Shinya Kitamura & Naoki Aikawa. (2006) Efficacy of Micafungin Sodium on Fungal Infection in Critical Care. Nippon Ishinkin Gakkai Zasshi 47:4, pages 293-297.
Crossref
Crossref